1-20 of 58
Boris Fehse
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutation Clearance of Driver Mutations after Transplantation for Myelofibrosis Predicts Outcome

Nico Gagelmann, Marie Quarder, Anita Badbaran, Christine Wolschke, Kristin Rathje, Mathias Schäfersküpper, Ameya Shrinivas Kunte, Evgeny Klyuchnikov, Radwan Massoud, Johanna Richter, Dietlinde Janson, Boris Fehse, Francis A. Ayuk, Nicolaus Kroeger
Journal: Blood
Blood (2023) 142 (Supplement 1): 630.
https://doi.org/10.1182/blood-2023-191242
Published: 2023
Journal Articles

Spectrum of ASXL1 Mutations Show Similar Impact on Outcomes in Patients with Myelofibrosis Undergoing Transplantation

Nico Gagelmann, Anita Badbaran, Christine Wolschke, Mathias Schäfersküpper, Dietlinde Janson, Francis A. Ayuk, Boris Fehse, Nicolaus Kroeger
Journal: Blood
Blood (2023) 142 (Supplement 1): 1843.
https://doi.org/10.1182/blood-2023-191280
Published: 2023
Journal Articles

Targeting Molecular Remission with Donor Lymphocyte Infusions Shows Excellent Outcomes for Persistent or Relapsed Myelofibrosis after Stem Cell Transplantation

Nico Gagelmann, Anita Badbaran, Christine Wolschke, Raissa Adjallé, Dietlinde Janson, Carolina Berger, Evgeny Klyuchnikov, Boris Fehse, Francis A. Ayuk, Nicolaus Kroeger
Journal: Blood
Blood (2022) 140 (Supplement 1): 7672–7673.
https://doi.org/10.1182/blood-2022-170107
Published: 2022
Journal Articles

Viral Reactivation and Immune Reconstitution after CAR-T Cell Treatment in Patients with Hematologic Malignancies

Ameya Shrinivas Kunte, Nico Gagelmann, Anita Badbaran, Carolina Berger, Radwan Massoud, Evgeny Klyuchnikov, Christine Wolschke, Dietlinde Janson, Ulrike Fritsche-Friedland, Boris Fehse, Nicolaus Kroeger, Francis A. Ayuk
Journal: Blood
Blood (2022) 140 (Supplement 1): 7531–7532.
https://doi.org/10.1182/blood-2022-168667
Published: 2022
Journal Articles

Impact of High-Risk Disease on Outcome after CAR-T Cell Therapy for Multiple Myeloma: A Meta-Analysis of 759 Patients

Nico Gagelmann, Francis A. Ayuk, Anita Badbaran, Carolina Berger, Boris Fehse, Nicolaus Kroeger
Journal: Blood
Blood (2022) 140 (Supplement 1): 7241–7242.
https://doi.org/10.1182/blood-2022-170061
Published: 2022
Journal Articles

CAR-HEMATOTOX: a model for CAR T-cell–related hematologic toxicity in relapsed/refractory large B-cell lymphoma

Kai Rejeski, Ariel Perez, Pierre Sesques, Eva Hoster, Carolina Berger, Liv Jentzsch, Dimitrios Mougiakakos, Lisa Frölich, Josephine Ackermann, Veit Bücklein, Viktoria Blumenberg, Christian Schmidt, Laurent Jallades, Boris Fehse, Christoph Faul, Philipp Karschnia, Oliver Weigert, Martin Dreyling, Frederick L. Locke, Michael von Bergwelt-Baildon, Andreas Mackensen, Wolfgang Bethge, Francis Ayuk, Emmanuel Bachy, Gilles Salles, Michael D. Jain, Marion Subklewe
Journal: Blood
Blood (2021) 138 (24): 2499–2513.
https://doi.org/10.1182/blood.2020010543
Published: 2021
Includes: Supplemental data
Journal Articles

Insights in ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia

Andreas Greinacher, Kathleen Selleng, Raghavendra Palankar, Jan Wesche, Stefan Handtke, Martina Wolff, Konstanze Aurich, Michael Lalk, Karen Methling, Uwe Völker, Christian Hentschker, Stephan Michalik, Leif Steil, Alexander Reder, Linda Schönborn, Martin Beer, Kati Franzke, Andreas Büttner, Boris Fehse, Evi X. Stavrou, Chandini Rangaswamy, Reiner K. Mailer, Hanna Englert, Maike Frye, Thomas Thiele, Stefan Kochanek, Lea Krutzke, Florian Siegerist, Nicole Endlich, Theodore E. Warkentin, Thomas Renné
Journal: Blood
Blood (2021) 138 (22): 2256–2268.
https://doi.org/10.1182/blood.2021013231
Published: 2021
Includes: Supplemental data
Journal Articles

Blockade of Mer By the Small Molecule Inhibitor R992 Inhibits Multiple Myeloma and Its Associated Bone Disease By Restoring the Perturbed Bone Homeostasis

Janik Engelmann, Isabel Ben Batalla, PhD, Hanna Taipaleenmäki, PhD, Kristoffer Riecken, PhD, Victoria Gensch, Sarina Paesler, Nikolaus Berenbrok, Maria Elena Vargas, Jonas Waizenegger, MD, Boris Fehse, PhD, Klaus Pantel, MD, PhD, Ihab S Darwish, PhD, Somasekhar Bhamidipati, PhD, Esteban Masuda, PhD, Carsten Bokemeyer, MD, PhD, Eric Hesse, MD, PhD, Sonja Loges, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1922.
https://doi.org/10.1182/blood-2018-99-118273
Published: 2018
Journal Articles

The phosphotyrosine phosphatase SHP2 promotes anergy in chronic lymphocytic leukemia

Simon Schliffke, Sophia Buhs, Sarah Bolz, Helwe Gerull, Lisa von Wenserski, Kristoffer Riecken, Boris Fehse, Peter Nollau, Mascha Binder
Journal: Blood
Blood (2018) 131 (15): 1755–1758.
https://doi.org/10.1182/blood-2017-06-788166
Published: 2018
Includes: Supplemental data
Journal Articles

Clones with and without Sensitivity Towards Treatment In Vivo Co-Exist within the Tumor Cells of a Single Patient with ALL

Cornelia Finkenzeller, MSc, Michela Carlet, PhD, Sebastian Vosberg, Christoph Ziegenhain, MSc, Martin Neumann, MD, Kristoffer Riecken, PhD, Kerstin Cornils, PhD, Boris Fehse, PhD, Claudia D. Baldus, MD, Wolfgang Enard, Prof. Dr. rer. nat., Philipp A. Greif, MD, Irmela Jeremias, MD
Journal: Blood
Blood (2016) 128 (22): 456.
https://doi.org/10.1182/blood.V128.22.456.456
Published: 2016
Journal Articles

Impact of Molecular Genetics on Disease-Free Survival in Myelofibrosis Patients Following Allogeneic Stem Cell Transplantation

Nicolaus Kroeger, MD, Victoria Panagiota, MD, Tatjana Zabelina, MD, Michelle Maria Araujo Cruz, MD, Rabia Shahswar, MD, Anita Badbaran, Ioanna N Triviai, PhD, Francis Ayuk, MD, Marten Gehlhaar, MD, Christine Wolschke, MD, Robin Bollin, MD, Ulrich Lehmann, MD, Christian Koenecke, MD, Anuhar Chaturvedi, PhD MS, BPharm, Haefaa Alchalby, MD, Michael Stadler, MD, Matthias Eder, MD, Maximilian Christopeit, MD, Gudrun Göhring, MD, Michael Koenigsmann, MD, Brigitte Schlegelberger, MD Prof., Hans Heinrich Kreipe, MD, Arnold Ganser, MD, Boris Fehse, PhD, Felicitas Thol, MD, Michael Heuser, MD
Journal: Blood
Blood (2015) 126 (23): 352.
https://doi.org/10.1182/blood.V126.23.352.352
Published: 2015
Journal Articles

Impact of Minimal Residual Disease after Allografting Detected By JAK2V617F, MPL or Calreticulin in Myelofibrosis Patients

Nicolaus Kroeger, Anita Badbaran, Tatjana Zabelina, MD, Maximilian Christopeit, MD, Christine Wolschke, MD, Francis Ayuk, MD, Axel R. Zander, Professor, Haefaa Alchalby, MD, Ulrike Bacher, Ioanna N Triviai, PhD, Boris Fehse, PhD
Journal: Blood
Blood (2015) 126 (23): 4343.
https://doi.org/10.1182/blood.V126.23.4343.4343
Published: 2015
Journal Articles

Development of a Digital-PCR Assay for Screening and Quantitative Monitoring of Calreticulin (CALR) Type-2 Positive Patients with Myelofibrosis Following Allogeneic Stem Cell Transplantation

Boris Fehse, PhD, Anita Badbaran, Maximilian Christopeit, MD, Tim Aranyossy, Francis Ayuk, MD, Christine Wolschke, MD, Nicolaus Kroeger
Journal: Blood
Blood (2015) 126 (23): 1959.
https://doi.org/10.1182/blood.V126.23.1959.1959
Published: 2015
Journal Articles

Prognostic Impact of Splicing Factor Mutations in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Victoria Panagiota, MD, Michael Heuser, MD, Michelle Maria Araujo Cruz, Anita Badbaran, Rabia Shahswar, Ioanna N Triviai, PhD, Boris Fehse, MD, Haefaa Alchalby, MD, Ulrich Lehmann, MD, Christian Koenecke, MD, Anuhar Chaturvedi, PhD, Michael Stadler, MD, Matthias Eder, MD, Gudrun Göhring, MD, Michael Koenigsmann, MD, Brigitte Schlegelberger, MD, Hans Heinrich Kreipe, MD, Arnold Ganser, MD, Felicitas Thol, MD, Nicolaus Kröger, MD
Journal: Blood
Blood (2014) 124 (21): 3171.
https://doi.org/10.1182/blood.V124.21.3171.3171
Published: 2014
Journal Articles

Fetomaternal Microchimerism Is Associated with Better Outcome in Haploidentical Hematopoietic Stem Cell Transplantation

Anne Kruchen, PhD, Tanja Stahl, Friederike Gieseke, PhD, Thomas MC Binder, MD, Zakir Oezcan, PhD, Roland Meisel, MD, Hermann Kreyenberg, PhD, Peter Bader, Bernd Gruhn, MD, Johann Greil, MD, Matthias Pfeiffer, MD, Michaela Doering, MD, Rupert Handgretinger, Boris Fehse, Prof, Ingo Mueller, MD
Journal: Blood
Blood (2014) 124 (21): 1242.
https://doi.org/10.1182/blood.V124.21.1242.1242
Published: 2014
Journal Articles

CD133 Marks a Stem Cell Population That Drives Human Primary Myelofibrosis

Ioanna Triviai, Dr, Thomas Stuebig, MD, Birte Niebuhr, PhD, Kais Hussein, MD, Asterios Tsiftsoglou, Prof, Boris Fehse, Prof, Carol Stocking, PhD, Nicolaus Kroeger, MD
Journal: Blood
Blood (2013) 122 (21): 1601.
https://doi.org/10.1182/blood.V122.21.1601.1601
Published: 2013
Journal Articles

Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma

Isabel Ben-Batalla, Alexander Schultze, Mark Wroblewski, Robert Erdmann, Michael Heuser, Jonas S. Waizenegger, Kristoffer Riecken, Mascha Binder, Denis Schewe, Stefanie Sawall, Victoria Witzke, Miguel Cubas-Cordova, Melanie Janning, Jasmin Wellbrock, Boris Fehse, Christian Hagel, Jürgen Krauter, Arnold Ganser, James B. Lorens, Walter Fiedler, Peter Carmeliet, Klaus Pantel, Carsten Bokemeyer, Sonja Loges
Journal: Blood
Blood (2013) 122 (14): 2443–2452.
https://doi.org/10.1182/blood-2013-03-491431
Published: 2013
Includes: Supplemental data
Journal Articles

SOCS3 promotes interleukin-17 expression of human T cells

Katja Kleinsteuber, Kerrin Heesch, Stefanie Schattling, Claudia Sander-Juelch, Ulrike Mock, Kristoffer Riecken, Boris Fehse, Bernhard Fleischer, Marc Jacobsen
Journal: Blood
Blood (2012) 120 (22): 4374–4382.
https://doi.org/10.1182/blood-2011-11-392738
Published: 2012
Includes: Supplemental data
Journal Articles

Detection of a Stem Cell Population with Hemangioblastic Characteristics in Primary Myelofibrosis (PMF),

Ioanna N Trivai, Thomas Stuebig, Anita Badbaran, Ursula Gehling, Asterios Tsiftsoglou, Boris Fehse, Nicolaus Kroeger, MD
Journal: Blood
Blood (2011) 118 (21): 3860.
https://doi.org/10.1182/blood.V118.21.3860.3860
Published: 2011
Journal Articles

Prognostic Significance and Target Potential of Axl in Acute Myeloid Leukemia

Alexander Schultze, M.D., M.Sc., Isabel Ben-Batalla, Ph.D., Michael Heuser, M.D., Kristoffer Weber, Ph.D., Robert Erdmann, Ph.D., Sacha Holland, Ph.D., Stefanie Sawall, Helena Fritz, M.Sc., Marc Tjwa, M.D., Ph.D., Thomas Schmidt, M.D., Walter Fiedler, M.D., Boris Fehse, Ph.D., Bjorn Dahlback, M.D., Klaus Pantel, M.D., Ph.D., Jürgen Krauter, Arnold Ganser, MD, Carsten Bokemeyer, M.D., Sonja Loges, M.D., Ph.D.
Journal: Blood
Blood (2011) 118 (21): 940.
https://doi.org/10.1182/blood.V118.21.940.940
Published: 2011